| Scorecard |
|---|
|
3 / 5 Stars
|
|
Lipper
5
5
1
4
1
|
|
Zacks Investment Research
1
(Strong Buy)
|
|
Standard & Poor's
4 / 5 Stars
|
|
TheStreet.com
C+
(Hold)
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 2.61 | 2.61 |
| Stocks | 3.63 | 3.63 |
| Bonds | 0.0 | 0.0 |
| Other | 1.53 | 1.53 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 92.23 | 92.23 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Laboratorios Almirall, S.A. | ALM | --- | 2.55 |
| Wirecard AG | WDI | --- | 1.77 |
| Spirax-Sarco Engineering PLC | SPXSF | 9.66 | 1.77 |
| MorphoSys AG | MOR | --- | 1.72 |
| Dunelm Group PLC | DNLM | --- | 1.63 |
| Swedish Orphan Biovitrum AB | SOBI | --- | 1.46 |
| Bruker Corporation | BRKR | 14.52 | 1.42 |
| Mahindra Satyam | SATYAMCOMP | --- | 1.36 |
| Bunzl PLC | BNZL | --- | 1.32 |
| Sirona Dental Systems, Inc. | SIRO | 13.16 | 1.27 |
